This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tues

Benzinga
Apri Benzinga
<?xml encoding="utf-8" ?>

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page .

B of A Securities analyst Tazeen Ahmad initiated coverage on Definium Therapeutics Inc (NASDAQ: DFTX ) with a Buy rating and announced a price target of $75. Definium Therapeutics closed at $45.26 on Monday. See how other analysts view this stock. B of A Securities analyst Miranda Zhuang initiated coverage on Kanzhun Ltd (NASDAQ: BZ ) with a Neutral rating and announced a price target of $74. Kanzhun shares closed at $15.55 on Monday. See how other analysts view this stock . Canaccord Genuity analyst Peter Bell initiated coverage on Sinda Ltd (NYSE: SIND ) with a Speculative Buy rating and announced a price target of $19. Sinda closed at $16.69 on Monday. See how other analysts view this stock . Chardan Capital analyst Andreas Argyrides initiated coverage on Rani Therapeutics Holdings Inc (NASDAQ: RANI ) with a Buy rating and announced a price target of $6. Rani Therapeutics shares closed at $0.80 on Monday. See how other analysts view this stock . Canaccord Genuity analyst Dalton Baretto initiated coverage on Sunshine Silver Mining & Refining Co (NYSE: SSMR ) with a Speculative Buy rating and announced a price target of $20. Sunshine Silver Mining closed at $16.00 on Monday. See how other analysts view this stock.

Considering buying DFTX stock? Here’s what analysts think:

Photo via Shutterstock

Latest Private Market Opportunities Join 400,000+ Investors

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here .


Posted In: Markets Trading Ideas News Analyst Ratings Initiation Top Initiations